Security key
64130M209
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)
CUSIP: 64130M209
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,477,622
- Total 13F shares
- 962,913
- Share change
- +240,777
- Total reported value
- $1,549,540
- Price per share
- $1.61
- Number of holders
- 14
- Value change
- +$453,337
- Number of buys
- 7
- Number of sells
- 9
Report period
Q1 2023
Institutions
14
Top holders
10
NMTC full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
NEUROONE MEDICAL TECHNOLOGIES Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64130M209
Recent filing periods:
Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic |
13F
|
Company |
2.1%
|
181,754
|
$218,105 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
114,249
|
$137,000 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
89,665
|
$107,598 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
85,926
|
$103,111 | — | 31 Dec 2022 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
64,203
|
$77,044 | — | 31 Dec 2022 | |
| MAI Capital Management |
13F
|
Company |
0.59%
|
50,000
|
$60,000 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
36,098
|
$43,318 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.42%
|
35,899
|
$43,079 | — | 31 Dec 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.25%
|
21,157
|
$25,388 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
19,933
|
$23,920 | — | 31 Dec 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.18%
|
14,939
|
$18,000 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
4,100
|
$5,000 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
2,699
|
$3,239 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,198
|
$1,438 | — | 31 Dec 2022 | |
| Belpointe Asset Management LLC |
13F
|
Company |
0.01%
|
682
|
$818 | — | 31 Dec 2022 | |
| MONEY CONCEPTS CAPITAL CORP |
13F
|
Company |
0%
|
113
|
$136 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
104
|
$125 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
34
|
$40 | — | 31 Dec 2022 | |
| AWM Investment Company, Inc. |
13F
|
Company |
—
class O/S missing
|
550,000
|
$660,000 | — | 31 Dec 2022 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q1 2023
As of 31 Mar 2023,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
962,913 shares.
The largest 10 holders included
VANGUARD GROUP INC, Mayo Clinic, GEODE CAPITAL MANAGEMENT, LLC, SG Americas Securities, LLC, MAI Capital Management, STATE STREET CORP, DRIVE WEALTH MANAGEMENT, LLC, NORTHERN TRUST CORP, Princeton Global Asset Management LLC, and Tower Research Capital LLC (TRC).
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
18
Q1 2023 holders
14
Holder diff
-4
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.